Myasthenia Gravis Trial, Recruiting (NCT06940323)

Myasthenia Gravis Trial, Recruiting NCT06940323 Sponsor: University of California, San Francisco Condition: Myasthenia Gravis

Printed from Voxsanity (voxsanity.com.au) — NCT06940323 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Myasthenia Gravis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are pregnant or thinking about becoming pregnant
You are a woman between 18 and 64 years old
You have been diagnosed with one of the following conditions: Clinically Isolated Syndrome (CIS) or Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD), Inflammatory Bowel Disease (IBD), Rheumatoid Arthritis (RA), Myasthenia Gravis, Lupus, or another long-term neurological condition
You are willing to provide biological samples (such as blood) and/or fill out surveys at certain points during the study
Women who do not have any chronic health condition but are pregnant or thinking about becoming pregnant may also be able to join as part of a comparison group

Who may not be able to join:

You are not willing to sign a consent form agreeing to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Riley Bove, MD, MSc, University of California, San Francisco

Phone: 415-502-7209

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06940323

Sponsor: University of California, San Francisco

Phase: Not Applicable

Status: Recruiting

Condition: Myasthenia Gravis

Trial contact: 415-502-7209

More information: https://clinicaltrials.gov/study/NCT06940323

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are pregnant or thinking about becoming pregnant
You are a woman between 18 and 64 years old
You have been diagnosed with one of the following conditions: Clinically Isolated Syndrome (CIS) or Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD), Inflammatory Bowel Disease (IBD), Rheumatoid Arthritis (RA), Myasthenia Gravis, Lupus, or another long-term neurological condition
You are willing to provide biological samples (such as blood) and/or fill out surveys at certain points during the study
Women who do not have any chronic health condition but are pregnant or thinking about becoming pregnant may also be able to join as part of a comparison group

Who may not be able to join:

You are not willing to sign a consent form agreeing to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, San Francisco

Registry

ClinicalTrials.gov

Start date

21 March 2017

Est. completion

1 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Maternal Disease Activity During Pregnancy and Postpartum Assessed by Expanded Disability Status Scale (EDSS); Maternal Disease Activity During Pregnancy and Postpartum Assessed by MRI Findings; Maternal Disease Treatment Course During Pregnancy and Postpartum Assessed by Disease Modifying Therapy (DMT) Use; Maternal Disease Activity During Pregnancy and Postpartum Assessed by Clinical Relapse Rates

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov